Back
Corvus Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
CRVS
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
CRVS
Corvus Pharmaceuticals
Last Price:
5.94
Seasonality Move:
-4.43%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corvus Pharmaceuticals Price Quote
$5.94
+0.01 (+7.03%)
(Updated: October 9, 2024 at 5:02 AM ET)
Corvus Pharmaceuticals Key Stats
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Day range:
$5.50 - $5.97
52-week range:
$1.05 - $6.15
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.25%
Volume:
341.1K
Avg. volume:
449.5K
1-year change:
298.32%
Market cap:
$371.2M
Revenue:
$0
EPS:
$-0.44
How Much Does Corvus Pharmaceuticals Make?
Data Unavailable
Is Corvus Pharmaceuticals Growing As A Company?
Data Unavailable
Corvus Pharmaceuticals Stock Price Performance
-
Did Corvus Pharmaceuticals Stock Go Up Last Month?
Corvus Pharmaceuticals share price went up by 47.27% last month -
Did CRVS's Share Price Rise Over The Last Year?
CRVS share price rose by 298.32% over the past 1 year
What Is Corvus Pharmaceuticals 52-Week High & Low?
-
What Is Corvus Pharmaceuticals’s 52-Week High Share Price?
Corvus Pharmaceuticals has traded as high as $6.15 over the past 52 weeks -
What Is Corvus Pharmaceuticals’s 52-Week Low Share Price?
Corvus Pharmaceuticals has traded as low as $1.05 over the past 52 weeks
Corvus Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Corvus Pharmaceuticals?
-
How Much Debt Does Corvus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Corvus Pharmaceuticals Have?
Cash and short term investments quarterly total is $47.2M -
What Is Corvus Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.82
Is Corvus Pharmaceuticals Cash Flow Positive?
-
What Is CRVS Cash Flow From Operations?
Cash flow from operations (TTM) is -$21.2M -
What Is Corvus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $30.7M -
What Is Corvus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3M
Corvus Pharmaceuticals Return On Invested Capital
Data Unavailable
Corvus Pharmaceuticals Earnings Date & Stock Price
-
What Is Corvus Pharmaceuticals's Stock Price Today?
A single share of CRVS can be purchased today for 5.94 -
What Is Corvus Pharmaceuticals’s Stock Symbol?
Corvus Pharmaceuticals trades on the nasdaq under the ticker symbol: CRVS -
When Is Corvus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Corvus Pharmaceuticals is scheduled on November 7, 2024 -
When Is CRVS's next ex-dividend date?
Corvus Pharmaceuticals's next ex-dividend date is October 9, 2024 -
How To Buy Corvus Pharmaceuticals Stock?
You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Corvus Pharmaceuticals Competitors
-
Who Are Corvus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Corvus Pharmaceuticals or are related in some way:
Corvus Pharmaceuticals Dividend Yield
-
What Is CRVS Dividend Yield?
Corvus Pharmaceuticals’s dividend yield currently is 0% -
What Is Corvus Pharmaceuticals’s Payout Ratio?
Corvus Pharmaceuticals’s payout ratio is 0% -
When Did Corvus Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 9, 2024 -
What Is Corvus Pharmaceuticals’s Dividend Per Share?
Corvus Pharmaceuticals pays a dividend of $0.00 per share
Corvus Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 39.13% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 10.13 |
Upside from Last Price: | 70.6% |